Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.

Show other versions (1)

Dihydroartemisinin-piperaquine is being increasingly used as a first-line artemisinin combination treatment for malaria. The aim of this study was to describe the pharmacokinetic and pharmacodynamic properties of piperaquine in 236 children with uncomplicated falciparum malaria in Burkina Faso. They...

Full description

Bibliographic Details
Main Authors:	Tarning, J, Zongo, I, Somé, F, Rouamba, N, Parikh, S, Rosenthal, P, Hanpithakpong, W, Jongrak, N, Day, N, White, N, Nosten, F, Ouedraogo, J, Lindegardh, N
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
by: Tarning, J, et al.
Published: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
by: Zongo, I, et al.
Published: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
by: Adam, I, et al.
Published: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
by: Adam, I, et al.
Published: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
by: Tarning, J, et al.
Published: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
by: Tarning, J, et al.
Published: (2012)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
by: Hoglund, R, et al.
Published: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
by: Rijken, M, et al.
Published: (2011)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
by: Tarning, J, et al.
Published: (2007)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
by: Tarning, J, et al.
Published: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
by: Tarning, J, et al.
Published: (2014)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
by: Tarning, J, et al.
Published: (2014)

Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border
by: Kloprogge, F, et al.
Published: (2015)

Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria.
by: Pukrittayakamee, S, et al.
Published: (2003)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
by: Tarning, J, et al.
Published: (2008)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
by: Creek, D, et al.
Published: (2013)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
by: Ashley, E, et al.
Published: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
by: Ashley, E, et al.
Published: (2010)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine in combination treatment of uncomplicated falciparum malaria in pediatric patients
by: Hietala, S, et al.
Published: (2009)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
by: Tarning, J, et al.
Published: (2012)

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
by: Ezzet, F, et al.
Published: (2000)

Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.
by: Kloprogge, F, et al.
Published: (2013)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
by: Mcgready, R, et al.
Published: (2006)

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
by: Hietala, S, et al.
Published: (2010)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
by: McGready, R, et al.
Published: (2009)

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
by: Hoglund, R, et al.
Published: (2017)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
by: Tarning, J, et al.
Published: (2007)

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
by: Kloprogge, F, et al.
Published: (2014)

Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.
by: Hendriksen, I, et al.
Published: (2013)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
by: Tarning, J, et al.
Published: (2009)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
by: Jamsen, K, et al.
Published: (2011)

Semimechanistic pharmacokinetic and pharmacodynamic modeling of piperaquine in a volunteer infection study with Plasmodium falciparum blood-stage malaria
by: Wattanakul, T, et al.
Published: (2021)

POPULATION PHARMACOKINETICS OF ANTIMALARIAL DRUGS IN THE TREATMENT OF PREGNANT WOMEN WITH UNCOMPLICATED MALARIA
by: Tarning, J, et al.
Published: (2010)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
by: Mytton, O, et al.
Published: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
by: Tarning, J, et al.
Published: (2008)

Pooled multicenter analysis of cardiovascular safety and population pharmacokinetic properties of piperaquine in African patients with uncomplicated falciparum Malaria
by: Wattanakul, T, et al.
Published: (2020)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
by: Tchaparian, E, et al.
Published: (2016)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Chotsiri, P, et al.
Published: (2019)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
by: Jamsen, K, et al.
Published: (2012)

Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
by: Zongo, I, et al.
Published: (2015)